Healthcare provider profile · identity verified

James D Stoll, MD

Internal Medicine · NEW ORLEANS, LA · NPI 1982630810

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	657	192
Amlodipine Besylate	Amlodipine Besylate	587	165
Losartan Potassium	Losartan Potassium	403	116
Hydrochlorothiazide	Hydrochlorothiazide	357	96
Gabapentin	Gabapentin	334	83
Levothyroxine Sodium	Levothyroxine Sodium	290	72
Pantoprazole Sodium	Pantoprazole Sodium	280	84
Rosuvastatin Calcium	Rosuvastatin Calcium	256	79
Metoprolol Succinate	Metoprolol Succinate	192	60
Allopurinol	Allopurinol	170	48
Omeprazole	Omeprazole	162	45
Lisinopril	Lisinopril	152	46
Furosemide	Furosemide	148	43
Trazodone Hcl	Trazodone Hcl	144	45
Valsartan	Valsartan	144	41
Tamsulosin Hcl	Tamsulosin Hcl	140	47
Eliquis	Apixaban	133	33
Metformin Hcl	Metformin Hcl	129	41
Sertraline Hcl	Sertraline Hcl	129	34
Potassium Chloride	Potassium Chloride	117	30
Carvedilol	Carvedilol	115	31
Alprazolam	Alprazolam	114	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	114	19
Pravastatin Sodium	Pravastatin Sodium	112	30
Fluticasone Propionate	Fluticasone Propionate	87	35
Alendronate Sodium	Alendronate Sodium	83	27
Metoprolol Tartrate	Metoprolol Tartrate	72	22
Famotidine	Famotidine	70	20
Clopidogrel	Clopidogrel Bisulfate	62	19
Albuterol Sulfate Hfa	Albuterol Sulfate	61	30
Escitalopram Oxalate	Escitalopram Oxalate	61	24
Meloxicam	Meloxicam	61	26
Citalopram Hbr	Citalopram Hydrobromide	59	16
Lorazepam	Lorazepam	54	11
Tramadol Hcl	Tramadol Hcl	52	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	51	suppressed
Ezetimibe	Ezetimibe	46	14
Finasteride	Finasteride	45	11
Nifedipine Er	Nifedipine	45	13
Tizanidine Hcl	Tizanidine Hcl	45	suppressed
Simvastatin	Simvastatin	44	13
Azithromycin	Azithromycin	43	36
Jardiance	Empagliflozin	41	suppressed
Trulicity	Dulaglutide	41	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	40	suppressed
Ondansetron Odt	Ondansetron	40	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	40	suppressed
Glimepiride	Glimepiride	38	suppressed
Duloxetine Hcl	Duloxetine Hcl	37	12
Chlorthalidone	Chlorthalidone	36	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	36	suppressed
Metformin Hcl Er	Metformin Hcl	36	11
Telmisartan	Telmisartan	36	suppressed
Atenolol	Atenolol	35	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	34	suppressed
Repatha Sureclick	Evolocumab	34	suppressed
Synthroid	Levothyroxine Sodium	34	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Januvia	Sitagliptin Phosphate	32	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	32	suppressed
Benazepril Hcl	Benazepril Hcl	31	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	31	27
Lovastatin	Lovastatin	31	suppressed
Ozempic	Semaglutide	30	suppressed
Montelukast Sodium	Montelukast Sodium	29	12
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	28	18
Fenofibrate	Fenofibrate	28	suppressed
Irbesartan	Irbesartan	28	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	27	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	27	suppressed
Methocarbamol	Methocarbamol	26	suppressed
Mupirocin	Mupirocin	26	11
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Oxycodone Hcl	Oxycodone Hcl	26	suppressed
Pregabalin	Pregabalin	26	suppressed
Ramipril	Ramipril	26	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	25	suppressed
Xarelto	Rivaroxaban	24	suppressed
Diclofenac Sodium	Diclofenac Sodium	23	suppressed
Cefdinir	Cefdinir	22	20
Clonazepam	Clonazepam	22	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Spironolactone	Spironolactone	22	suppressed
Diazepam	Diazepam	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Glipizide Er	Glipizide	21	suppressed
Ketoconazole	Ketoconazole	21	suppressed
Lactulose	Lactulose	21	suppressed
Clonidine	Clonidine	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	20	12
Hydralazine Hcl	Hydralazine Hcl	20	11
Lidocaine	Lidocaine	20	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	16
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Symbicort	Budesonide/Formoterol Fumarate	19	suppressed
Topiramate	Topiramate	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	17	suppressed
Farxiga	Dapagliflozin Propanediol	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Felodipine Er	Felodipine	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Chlordiazepoxide Hcl	Chlordiazepoxide Hcl	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Torsemide	Torsemide	13	suppressed
Chlorzoxazone	Chlorzoxazone	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Phenobarbital	Phenobarbital	12	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error